Difficulty: Medium
Average Score: 82%
Practice
Granulocytic sarcoma masses are commonly seen in which type of the following malignancies?
Correct answer
D
Rationale
In pediatric oncology, granulocytic sarcoma masses are commonly associated with Acute Myeloid Leukemia (AML). AML is a type of cancer that starts in the bone marrow and can spread to other parts of the body, including soft tissues. Granulocytic sarcoma is an extramedullary tumor composed of immature granulocytic cells, often found in patients with AML. This connection between AML and granulocytic sarcoma makes option D the correct answer.
Option A, neuroblastoma, is a cancer that arises from immature nerve cells and is not typically associated with granulocytic sarcoma. Rhabdomyosarcoma (option B) is a soft tissue cancer that arises from muscle cells, not from granulocytic cells. Soft tissue sarcoma (option C) includes a variety of cancers that originate in soft tissues like muscle, fat, or blood vessels, but not specifically from granulocytic cells as seen in AML.
Educationally, understanding the specific associations between certain malignancies and tumor types is crucial for accurate diagnosis and treatment in pediatric oncology. Recognizing the relationship between granulocytic sarcoma and AML can guide healthcare providers in appropriate management strategies and improve patient outcomes.
Option A, neuroblastoma, is a cancer that arises from immature nerve cells and is not typically associated with granulocytic sarcoma. Rhabdomyosarcoma (option B) is a soft tissue cancer that arises from muscle cells, not from granulocytic cells. Soft tissue sarcoma (option C) includes a variety of cancers that originate in soft tissues like muscle, fat, or blood vessels, but not specifically from granulocytic cells as seen in AML.
Educationally, understanding the specific associations between certain malignancies and tumor types is crucial for accurate diagnosis and treatment in pediatric oncology. Recognizing the relationship between granulocytic sarcoma and AML can guide healthcare providers in appropriate management strategies and improve patient outcomes.